@article{1763728f7a194f63968b5db9b08f29ce,
title = "Tissue-Resident PDGFRα+ Progenitor Cells Contribute to Fibrosis versus Healing in a Context- and Spatiotemporally Dependent Manner",
abstract = "PDGFRα+ mesenchymal progenitor cells are associated with pathological fibro-adipogenic processes. Conversely, a beneficial role for these cells during homeostasis or in response to revascularization and regeneration stimuli is suggested, but remains to be defined. We studied the molecular profile and function of PDGFRα+ cells in order to understand the mechanisms underlying their role in fibrosis versus regeneration. We show that PDGFRα+ cells are essential for tissue revascularization and restructuring through injury-stimulated remodeling of stromal and vascular components, context-dependent clonal expansion, and ultimate removal of pro-fibrotic PDGFRα+-derived cells. Tissue ischemia modulates the PDGFRα+ phenotype toward cells capable of remodeling the extracellular matrix and inducing cell-cell and cell-matrix adhesion, likely favoring tissue repair. Conversely, pathological healing occurs if PDGFRα+-derived cells persist as terminally differentiated mesenchymal cells. These studies support a context-dependent “yin-yang” biology of tissue-resident mesenchymal progenitor cells, which possess an innate ability to limit injury expansion while also promoting fibrosis in an unfavorable environment.",
keywords = "Brainbow, fibrosis, hindlimb ischemia, platelet-derived growth factor receptor α, regeneration, revascularization, RNA sequencing",
author = "Santini, {Maria Paola} and Daniela Malide and Gabriel Hoffman and Gaurav Pandey and Valentina D'Escamard and Aya Nomura-Kitabayashi and Ilsa Rovira and Hiroshi Kataoka and Jordi Ochando and Harvey, {Richard P.} and Toren Finkel and Kovacic, {Jason C.}",
note = "Funding Information: We thank Fondation Leducq (Transatlantic Network of Excellence Awards) for funding these analyses. We acknowledge the assistance of the Microscopy, Genomics and Multiscale Biology, Histopathology, and Flow Cytometry Core Facilities at Icahn School of Medicine at Mount Sinai (ISMMS). M.P.S. acknowledges support from the National Institutes of Health (NIH) (R01HL135093). G.P. acknowledges support from the NIH (R01GM114434). V.D. and A.N.-K. were supported by NIH grant T32HL007824. J.C.K. acknowledges support from Fondation Leducq and the NIH (R01HL135093 and R01HL130423). R.P.H. acknowledges support from the National Health and Medical Research Council of Australia (NHMRC) (APP1118576 and 1074386), the Australian Research Counsel Special Initiative in Stem Cell Science (SR110001002), Foundation Leducq (15 CVD 03, 13 CVD 01), and the New South Wales Government Department of Health. T.F. is supported by the Fondation Leducq and the Progeria Research Foundation. M.P.S. and J.C.K. conceived and designed the studies, interpreted and analyzed the data, and wrote the manuscript; M.P.S. performed the experiments; G.H. and G.P. performed the bioinformatic analyses; V.D. assisted with the animal work; A.N.-K. assisted with immunofluorescence studies; D.M. I.R. and T.F. assisted with the Brainbow study; J.O. assisted with the flow cytometry analysis and data interpretation; R.P.H. assisted with the data interpretation and revision of the manuscript; and H.K. provided the PdgfrαMCM mice. All of the authors discussed the results and commented on the manuscript. R.P.H. declares a patent filed in the name of University of Sydney, Victor Chang Cardiac Research Institute, covering the use of the PDGF-AB ligand as a therapy for cardiovascular events, including myocardial infarction. Status: Provisional patent and PCT submitted, priority data 14.06.18. The other authors declare no competing interests. Funding Information: We thank Fondation Leducq (Transatlantic Network of Excellence Awards) for funding these analyses. We acknowledge the assistance of the Microscopy, Genomics and Multiscale Biology, Histopathology, and Flow Cytometry Core Facilities at Icahn School of Medicine at Mount Sinai (ISMMS). M.P.S. acknowledges support from the National Institutes of Health ( NIH ) ( R01HL135093 ). G.P. acknowledges support from the NIH ( R01GM114434 ). V.D. and A.N.-K. were supported by NIH grant T32HL007824 . J.C.K. acknowledges support from Fondation Leducq and the NIH ( R01HL135093 and R01HL130423 ). R.P.H. acknowledges support from the National Health and Medical Research Council of Australia ( NHMRC ) ( APP1118576 and 1074386 ), the Australian Research Counsel Special Initiative in Stem Cell Science ( SR110001002 ), Foundation Leducq ( 15 CVD 03 , 13 CVD 01 ), and the New South Wales Government Department of Health . T.F. is supported by the Fondation Leducq and the Progeria Research Foundation . Publisher Copyright: {\textcopyright} 2019 The Author(s)",
year = "2020",
month = jan,
day = "14",
doi = "10.1016/j.celrep.2019.12.045",
language = "English",
volume = "30",
pages = "555--570.e7",
journal = "Cell Reports",
issn = "2211-1247",
publisher = "Cell Press",
number = "2",
}